What's different about older people.

Area of Science:

• Gerontology
• Clinical Pharmacology
• Health Services Research

Background:

• Older adults are a marginalized group, particularly in healthcare.
• They experience a "double whammy" with medication: higher risk of adverse effects and limited clinical trial involvement.
• This necessitates rational prescribing to maximize benefits and minimize risks.

Purpose of the Study:

• To address the challenges of medication use and clinical trial participation in older adults.
• To highlight the need for age-specific considerations in drug development and prescribing.
• To advocate for improved inclusion of older individuals in clinical research.

Main Methods:

• Review of early studies on medication compliance, poly-pharmacy, and adverse drug effects in older populations.
• Examination of pharmacokinetic differences between older adults and younger volunteers.
• Analysis of challenges in recruiting and conducting clinical trials with older participants.

Main Results:

• Age-related pharmacokinetic differences are less pronounced than initially thought, except for renal clearance.
• "Start low and go slow" is a common but not universally applicable approach.
• Adverse events in older adults can have more severe consequences (e.g., falls leading to fractures).

Conclusions:

• Older adults require tailored approaches to medication management and clinical trial design.
• Quality of life is a critical endpoint in trials for older individuals.
• Despite stated intentions, arbitrary age limits persist in clinical trials, hindering evidence generation.